Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV
12:05
Why We've Only Cured HIV Seven Times
5:41
Impact of PEPFAR Funding Pause on Nigeria's HIV/AIDS Response
3:45
DeepSeek and distillation: Why the AI race will never be the same
4:36
FULL REMARKS: White House press secretary gaggles with reporters early Wednesday
26:26
About 50% Of Jobs Will Be Displaced By AI Within 3 Years
7:04
New HIV drug 100% effective - but why does it cost $40,000?
2:38
White House reacts to federal funding memo reversal
1:37:34